Epigenomics Deal Gives Roche Access To DNA Methylation Cancer Tests
This article was originally published in The Gray Sheet
Executive Summary
Roche can expect to have DNA methylation-based cancer screening assays available to reference labs by 2006 under a collaboration with Epigenomics